102 related articles for article (PubMed ID: 1411390)
1. [Acute alveolitis due to mesalazine].
Lagler U; Schulthess HK; Kuhn M
Schweiz Med Wochenschr; 1992 Sep; 122(36):1332-4. PubMed ID: 1411390
[TBL] [Abstract][Full Text] [Related]
2. Mesalazine alveolitis.
Welte T; Hamm H; Fabel H
Lancet; 1991 Nov; 338(8777):1273. PubMed ID: 1682668
[No Abstract] [Full Text] [Related]
3. [Drug safety, acceptance and effectiveness of 5-aminosalicylic acid (mesalazine) in the treatment of ulcerative colitis and Crohn disease].
Bayerdörffer E; Bock H
Leber Magen Darm; 1988 Apr; 18(2):104-13. PubMed ID: 3374251
[TBL] [Abstract][Full Text] [Related]
4. [Pericarditis during inflammatory bowel diseases. Extra-intestinal or iatrogenic complication?].
Heresbach D; Rabot A; Génetet N; Marteau P; Stéphan C; Bretagne JF; Gosselin M
Gastroenterol Clin Biol; 1994; 18(8-9):782-5. PubMed ID: 7875451
[TBL] [Abstract][Full Text] [Related]
5. Mesalamine lung toxicity.
Jain N; Petruff C; Bandyopadhyay T
Conn Med; 2010 May; 74(5):265-7. PubMed ID: 20509416
[TBL] [Abstract][Full Text] [Related]
6. Asacol: mesalazine for ulcerative colitis.
Drug Ther Bull; 1986 May; 24(10):38-40. PubMed ID: 3709355
[No Abstract] [Full Text] [Related]
7. [Ulcerative colitis and pericarditis. The role of mesalazine hypersensitivity].
Loizeau E
Rev Med Suisse Romande; 1995 Nov; 115(11):935-8. PubMed ID: 8525252
[No Abstract] [Full Text] [Related]
8. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine.
Nakajima H; Munakata A; Yoshida Y
J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870
[TBL] [Abstract][Full Text] [Related]
9. Balsalazide is superior to mesalamine in the time to improvement of signs and symptoms of acute mild-to-moderate ulcerative colitis.
Pruitt R; Hanson J; Safdi M; Wruble L; Hardi R; Johanson J; Koval G; Riff D; Winston B; Cross A; Doty P; Johnson LK
Am J Gastroenterol; 2002 Dec; 97(12):3078-86. PubMed ID: 12492193
[TBL] [Abstract][Full Text] [Related]
10. [Ulcerative colitis. Evaluation of a newly developed activity index within the scope of a therapeutic study of mesalazin].
Maier K; von Gaisberg U; Kraus B; Kimmig JM; Tippmann P; Gerhard F; Lepiorz P
Fortschr Med; 1987 Jan; 105(2):61, 65-6, 69. PubMed ID: 3557255
[No Abstract] [Full Text] [Related]
11. [Pentasa (mesalazine) and pregnancy].
Jonville-Bera AP; Soyez C; Fignon A; Moraine C; Berger C; Autret E
Therapie; 1994; 49(5):443-5. PubMed ID: 7855761
[TBL] [Abstract][Full Text] [Related]
12. [Characterization of proteinuria in patients with ulcerative colitis and therapy with aminosalicylates].
Buschhausen L; Kruis W; Aymaz S; Weber M; Krakamp B
Med Klin (Munich); 2006 Oct; 101(10):791-5. PubMed ID: 17039321
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
Levine DS; Riff DS; Pruitt R; Wruble L; Koval G; Sales D; Bell JK; Johnson LK
Am J Gastroenterol; 2002 Jun; 97(6):1398-407. PubMed ID: 12094857
[TBL] [Abstract][Full Text] [Related]
14. Mesalamine-induced lung toxicity.
Bitton A; Peppercorn MA; Hanrahan JP; Upton MP
Am J Gastroenterol; 1996 May; 91(5):1039-40. PubMed ID: 8633548
[TBL] [Abstract][Full Text] [Related]
15. Mesalamine and olsalazine: 5-aminosalicylic acid agents for the treatment of inflammatory bowel disease.
Segars LW; Gales BJ
Clin Pharm; 1992 Jun; 11(6):514-28. PubMed ID: 1600685
[TBL] [Abstract][Full Text] [Related]
16. [Tubulointerstitial nephritis caused by mesalazine (5-ASA) agents].
Smilde TJ; van Liebergen FJ; Koolen MI; Gerlag PG; Assmann KJ; Berden JH
Ned Tijdschr Geneeskd; 1994 Dec; 138(51):2557-61. PubMed ID: 7830805
[TBL] [Abstract][Full Text] [Related]
17. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis.
Tursi A; Brandimarte G; Giorgetti GM; Forti G; Modeo ME; Gigliobianco A
Med Sci Monit; 2004 Nov; 10(11):PI126-31. PubMed ID: 15507864
[TBL] [Abstract][Full Text] [Related]
18. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.
Sviri S; Gafanovich I; Kramer MR; Tsvang E; Ben-Chetrit E
J Clin Gastroenterol; 1997 Jan; 24(1):34-6. PubMed ID: 9013348
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity to 5-aminosalicylic acid in patients with ulcerative colitis.
Niv Y
Isr J Med Sci; 1987 Nov; 23(11):1161-3. PubMed ID: 3436802
[No Abstract] [Full Text] [Related]
20. [Aminosalicylates in the treatment of chronic inflammatory bowel diseases].
Hartmann F; Plauth M
Internist (Berl); 1990 Nov; 31(11):702-6. PubMed ID: 2289856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
